664 af de patienter, som modtog vildagliptin 50 mg én gang daglig eller 100 mg daglig, var ≥ 65 år, og 121 af patienterne var ≥ 75 år.
The number of patients receiving vildagliptin 50 mg once daily or 100 mg daily who were ≥ 65 years of age was 664 and 121 of the patients were ≥ 75 years of age.